11 completed. 11 Phase 2, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 11 |
| Phase 1 | 5 | Completed 5 |
Follow Milk Hypersensitivity: new trials by email Literature Review of Milk Hypersensitivity trials Research Report on Milk Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| Baked Milk Oral Immunotherapy for Cow's Milk Allergy Baked non-fat cow's milk powder, Placebo: Tapioca Powder - Cow's Milk Allergy | Phase 2 | Completed | Johns Hopkins University | 41 | 2018-03-15 | 2025-02-04 |
| Milk Patch for Eosinophilic Esophagitis Viaskin Milk 500 mcg, Viaskin Placebo - Eosinophilic Esophagitis, Milk Allergy | Phase 2 | Completed | Children's Hospital of Philadelphia | 20 | 2015-10-01 | 2019-07-10 |
| The Effect of Baked Milk on Cow's Milk Allergy Baked Milk - Cow's Milk Allergy | Phase 2 | Completed | Hossein Esmaielzadeh | 100 | 2015-09-01 | 2018-04-25 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy | Phase 1 / Phase 2 | Completed | DBV Technologies | 198 | 2014-11-01 | 2024-11-20 |
| Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy Amix - Cow's Milk Allergy | Phase 2 | Completed | Edetec Indústria Alimentícia S.A. | 15 | 2013-08-01 | 2015-08-31 |
| OIT and Xolair® (Omalizumab) in Cow's Milk Allergy Placebo for omalizumab, Omalizumab, Milk powder - Milk Allergy | Phase 2 | Completed | Hugh A Sampson, MD | 77 | 2010-08-01 | 2020-08-14 |
| The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy Milk Protein Extract Immunotherapy goal of 4mg/day, Milk Protein Extract Immunotherapy goal of 7mg/day, Milk Powder Immunotherapy goal dose 2000 mg/day - Milk Allergy | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 30 | 2008-08-01 | 2017-05-15 |
| Study of Milk Allergy and Tolerance in Children Baked Milk, Non-baked Milk - Food Hypersensitivity, Milk Hypersensitivity | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 170 | 2008-08-01 | 2016-03-30 |
| A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy cow's milk powder, Placebo - Milk Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2006-08-01 | 2017-04-20 |
| Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques). Procedure - Milk Allergy | Phase 1 / Phase 2 | Completed | Nambudripad's Allergy Research Foundation | 26 | 2005-01-01 | 2006-05-22 |
Food Hypersensitivity (7) · Hypersensitivity (2) · Egg Hypersensitivity (1) · Eosinophilic Esophagitis (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Nut Hypersensitivity (1) · Peanut Hypersensitivity (1) · Shellfish Hypersensitivity (1) · Wheat Hypersensitivity (1)
Hypersensitivity, Immediate (10) · Immune System Diseases (10) · Hypersensitivity (9) · Food Hypersensitivity (4) · Digestive System Diseases (1) · Eosinophilia (1) · Esophageal Diseases (1) · Esophagitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukocyte Disorders (1) · Nut and Peanut Hypersensitivity (1)
Drugs, Investigational (1) · Methods (1) · Omalizumab (1) · Refit milk powder (1)
Johns Hopkins University (3) · Alladapt Immunotherapeutics, Inc. (1) · Children's Hospital of Philadelphia (1) · DBV Technologies (1) · Edetec Indústria Alimentícia S.A. (1) · Hossein Esmaielzadeh (1) · Hugh A Sampson, MD (1) · Nambudripad's Allergy Research Foundation (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (9) · Canada (1) · Iran (1)
Robert Wood, MD (2) · Anna Nowak-Wegrzyn, MD (1) · Antonella Cianferoni, MD, PhD (1) · Devi S Nambudripad, DC,PhD,L.Ac (1) · Hossein Esmaeilzadeh (1) · Hugh A. Sampson, M.D. (1) · Hugh A. Sampson, MD (1) · Mei-Lun Wang, MD (1) · Robert A Wood, MD (1) · Wendel O Afonso, Master (1)
PMID 18951617, PMID 25609353, PMID 26581915, PMID 30027590, PMID 31100455, PMID 33006765, PMID 38407859, PMID 39782691
U19AI044236 (1)